Monday, June 4, 2007 - 18:26

Innate Pharma S.A. announced that a set of pharmacological data, from Research to clinical Phase II, of its drug candidate IPH 1101 was presented at the "American Society of Clinical Oncology" annual meeting.

AttachmentSize
PR in english141.72 KB
CP en français141.53 KB